Andrew Huberman· PhD
And so, you know, there's data from experimental patients receiving this. There's data from people that are chronic users, you know, who only take MDMA. And that combination of data suggests that there's certainly no apparent risk in the kind of one to two to three dose range. And it's probably unlikely that at least, you know, modest dose exposure over a lifetime doesn't appear to have a profound neurocognitive damaging effect, yeah.